Skyhawk Therapeutics Alternatives & Competitors
12 companies similar to Skyhawk Therapeutics — We Use Small Molecules To Modify RNA Splicing
Companies similar to Skyhawk Therapeutics
Nimbus Therapeutics
We develop breakthrough medicines for patients through precision small molecule design.
Boston, United States
TransCode Therapeutics, Inc.
Delivering a cancer-free future
Newton, United States
1910 Genetics
Advancing small and large molecule drug discovery with a multimodal AI platform powered by...
Boston, United States
Rgenta Therapeutics Inc.
We unlock the therapeutic potentials of highly disease-relevant targets undruggable by sma...
Woburn, United States
Track all Skyhawk Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Atavistik Bio
Precision allosteric therapeutics inspired by the body’s natural regulators
Cambridge, United States
Harmonic Discovery
Embedding the complexity of disease into the drug discovery process
New York, United States
CAMP4 Therapeutics
Advancing a pipeline of ASO-based, RNA-targeting therapeutics with the aim to restore heal...
Cambridge, United States
Astex Pharmaceuticals
Committed to the fight against cancer and CNS disorders
Cambridge, United Kingdom
PIC Therapeutics
Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes
Natick, United States
Orna Therapeutics
Wholly Owned Subsidiary of Eli Lilly and Company
Watertown, United States
Expansion Therapeutics
Bringing transformative therapies to patients with severe RNA-mediated diseases.
Jupiter, United States
Asceneuron SA
Targeting the root cause of neurodegeneration
Lausanne, Switzerland
About Skyhawk Therapeutics
Skyhawk Therapeutics, founded in 2016, is at the forefront of drug discovery and development within the Biotechnology and Health and Wellness industries. Stationed in Waltham, Massachusetts, this innovative company is pioneering the treatment of diseases with small molecules designed to modify RNA splicing. Underpinned...
Development of RNA-targeting small molecules, Conducting clinical trials, Collaborative drug development with pharma companies, Expanding internal pipeline for neurology, oncology, and fibrotic diseases
Patients with Huntington's Disease, Pharmaceutical Companies, Biotechnology Researchers
Small Molecule Therapeutics, RNA Splicing Modification, Drug Discovery, RNA-based Disease Treatment, Cancer Therapeutics, Neurological Condition Treatments, Proprietary Technology, Therapeutics Development, Exon Skipping, RNA Expression Correction, Binding Pocket Targeting, Sequence Specificity, Structural Specificity, Waltham-based
B2B, Platform
Licensing, Performance Based, Project Based
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Skyhawk Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Skyhawk Therapeutics on 15 Jun 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 22 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
